BIOMAT Database Logo BIOMAT Database Logo

[Use of prodigiozan in the complex therapy of dysentery]. 1973

V I Pokrovskiĭ, and V P Mashilov, and V A Utekhin, and N D Iushchuk, and L K Kasatskaia

UI MeSH Term Description Entries
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D004405 Dysentery, Bacillary DYSENTERY caused by gram-negative rod-shaped enteric bacteria (ENTEROBACTERIACEAE), most often by the genus SHIGELLA. Shigella dysentery, Shigellosis, is classified into subgroups according to syndrome severity and the infectious species. Group A: SHIGELLA DYSENTERIAE (severest); Group B: SHIGELLA FLEXNERI; Group C: SHIGELLA BOYDII; and Group D: SHIGELLA SONNEI (mildest). Shigellosis,Dysentery, Shiga bacillus,Dysentery, Shigella boydii,Dysentery, Shigella dysenteriae,Dysentery, Shigella dysenteriae type 1,Dysentery, Shigella flexneri,Dysentery, Shigella sonnei,Shigella Dysentery,Shigella Infection,Bacillary Dysentery,Dysenteries, Shigella,Dysenteries, Shigella boydii,Dysenteries, Shigella dysenteriae,Dysenteries, Shigella flexneri,Dysenteries, Shigella sonnei,Dysentery, Shigella,Infection, Shigella,Infections, Shigella,Shiga bacillus Dysentery,Shigella Dysenteries,Shigella Infections,Shigella boydii Dysenteries,Shigella boydii Dysentery,Shigella dysenteriae Dysenteries,Shigella dysenteriae Dysentery,Shigella flexneri Dysenteries,Shigella flexneri Dysentery,Shigella sonnei Dysenteries,Shigella sonnei Dysentery
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012706 Serratia marcescens A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in soil, water, food, and clinical specimens. It is a prominent opportunistic pathogen for hospitalized patients.

Related Publications

V I Pokrovskiĭ, and V P Mashilov, and V A Utekhin, and N D Iushchuk, and L K Kasatskaia
[Use of prodigiozan in the complex therapy of burns].
January 1971, Antibiotiki,
V I Pokrovskiĭ, and V P Mashilov, and V A Utekhin, and N D Iushchuk, and L K Kasatskaia
[Use of prodigiozan in the complex therapy of acute pneumonia].
December 1970, Klinicheskaia meditsina,
V I Pokrovskiĭ, and V P Mashilov, and V A Utekhin, and N D Iushchuk, and L K Kasatskaia
[Use of prodigiozan for increasing the effectiveness of the antibiotic therapy of dysentery in children].
October 1984, Antibiotiki,
V I Pokrovskiĭ, and V P Mashilov, and V A Utekhin, and N D Iushchuk, and L K Kasatskaia
[Role of prodigiozan in the overall therapy of dysentery in children].
January 1976, Zdravookhranenie Kirgizii,
V I Pokrovskiĭ, and V P Mashilov, and V A Utekhin, and N D Iushchuk, and L K Kasatskaia
[Effectiveness of thymalin and prodigiozan in the complex treatment of patients with dysentery].
July 1985, Voenno-meditsinskii zhurnal,
V I Pokrovskiĭ, and V P Mashilov, and V A Utekhin, and N D Iushchuk, and L K Kasatskaia
[Use of polysaccharide prodigiozan in the complex therapy of chronic and residual brucellosis].
June 1971, Antibiotiki,
V I Pokrovskiĭ, and V P Mashilov, and V A Utekhin, and N D Iushchuk, and L K Kasatskaia
[Use of prodigiozan in complex treatment of endogenous infections].
January 1980, Terapevticheskii arkhiv,
V I Pokrovskiĭ, and V P Mashilov, and V A Utekhin, and N D Iushchuk, and L K Kasatskaia
[Experiences with the use of Prodigiozan in therapy of prostatitis].
October 1973, Antibiotiki,
V I Pokrovskiĭ, and V P Mashilov, and V A Utekhin, and N D Iushchuk, and L K Kasatskaia
[Use of calcium preparations in complex therapy of salmonellosis and acute dysentery].
January 1981, Terapevticheskii arkhiv,
V I Pokrovskiĭ, and V P Mashilov, and V A Utekhin, and N D Iushchuk, and L K Kasatskaia
[Complex treatment of late radiation injuries of the skin by use of prodigiozan].
October 1969, Antibiotiki,
Copied contents to your clipboard!